Atropine Auto-Injectors (0.5 mg, 1 mg, and 2 mg)
Funding to support work on atropine auto-injectors in 0.5 mg, 1 mg, and 2 mg strengths, which are used for rapid treatment of certain poisonings (such as organophosphate/nerve agent exposure). Suitable for organizations that can develop, manufacture, test, or supply these devices to strengthen emergency and public health preparedness.
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers